BridgeMD
New treatment option for Cystic Fibrosis (CF)
Official title Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor
ClinicalTrials.gov ID: NCT07314229
What this study is testing
- What it's testing
- Cystic fibrosis is a genetic disorder affecting the entire body and associated with respiratory exacerbations, impaired quality of life and reduced life expectancy. The therapeutic management of cystic fibrosis has been profoundly changed by the recent arrival of a combination of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators, Elexacaftor-Tezacaftor-Ivacaftor (ETI), which improve quality of life, respiratory function and reducing the number of exacerbations.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female
- Adult aged 18 or over
- Suffering from cystic fibrosis
- Treated at the CRCM in Lille and Créteil
- Treated by ETI
You likely can't join if
- Medical contraindication or inability to perform a stress test according to ERS recommendations
- Absolute contraindications
- Relative contraindications:
- Exacerbation of the condition in the 4 weeks preceding the V1 visit (27).
- Pregnant or breastfeeding women
- Administrative reasons
See the full eligibility criteria
- Male or female
- Adult aged 18 or over
- Suffering from cystic fibrosis
- Treated at the CRCM in Lille and Créteil
- Treated by ETI
- Be covered by social security
- Be able to understand the requirements of the study, provide written informed consent, and comply with the study's data collection procedures
- Medical contraindication or inability to perform a stress test according to ERS recommendations
- Absolute contraindications
- Relative contraindications:
- Exacerbation of the condition in the 4 weeks preceding the V1 visit (27).
- Pregnant or breastfeeding women
- Administrative reasons
- Persons deprived of their liberty
- Minors or protected adults
- Persons who have refused or are unable to give informed consent
- Persons in emergency situations
The study team makes the final eligibility decision.
Where it's taking place
- Lille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.